tradingkey.logo
tradingkey.logo
Suchen

Chemed Corp

CHE
Zur Watchlist hinzufügen
466.000USD
+6.100+1.33%
Handelsschluss 06/30, 16:00ETKurse um 15 Minuten verzögert
6.16BMarktkapitalisierung
25.38KGV TTM

mehr Informationen über Chemed Corp Unternehmen

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.

Chemed Corp Informationen

BörsenkürzelCHE
Name des UnternehmensChemed Corp
IPO-datumMay 27, 1971
CEOMcnamara (Kevin J)
Anzahl der mitarbeiter15695
WertpapierartOrdinary Share
GeschäftsjahresendeMay 27
Addresse255 E. Fifth Street,
StadtCINCINNATI
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl45202
Telefon15137626690
Websitehttps://www.chemed.com/
BörsenkürzelCHE
IPO-datumMay 27, 1971
CEOMcnamara (Kevin J)

Führungskräfte von Chemed Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Thomas Charles Hutton, J.D.
Mr. Thomas Charles Hutton, J.D.
Director
Director
78.54K
+0.03%
Mr. Spencer S. Lee
Mr. Spencer S. Lee
Executive Vice President
Executive Vice President
14.91K
+2.31%
Dr. Andrea R. Lindell
Dr. Andrea R. Lindell
Independent Director
Independent Director
4.58K
-29.42%
Mr. Patrick P. Grace
Mr. Patrick P. Grace
Independent Director
Independent Director
3.72K
+8.76%
Mr. Christopher J. Heaney
Mr. Christopher J. Heaney
Independent Director
Independent Director
2.77K
+13.91%
Mr. Brian C. Judkins
Mr. Brian C. Judkins
Vice President, Chief Legal Officer, Secretary
Vice President, Chief Legal Officer, Secretary
2.44K
+10.22%
Mr. Ron DeLyons
Mr. Ron DeLyons
Independent Director
Independent Director
2.05K
+18.81%
Ms. Eileen P. Mccarthy
Ms. Eileen P. Mccarthy
Independent Director
Independent Director
1.24K
+31.10%
Mr. Kevin J. Mcnamara
Mr. Kevin J. Mcnamara
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. George J. Walsh, III
Mr. George J. Walsh, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Thomas Charles Hutton, J.D.
Mr. Thomas Charles Hutton, J.D.
Director
Director
78.54K
+0.03%
Mr. Spencer S. Lee
Mr. Spencer S. Lee
Executive Vice President
Executive Vice President
14.91K
+2.31%
Dr. Andrea R. Lindell
Dr. Andrea R. Lindell
Independent Director
Independent Director
4.58K
-29.42%
Mr. Patrick P. Grace
Mr. Patrick P. Grace
Independent Director
Independent Director
3.72K
+8.76%
Mr. Christopher J. Heaney
Mr. Christopher J. Heaney
Independent Director
Independent Director
2.77K
+13.91%
Mr. Brian C. Judkins
Mr. Brian C. Judkins
Vice President, Chief Legal Officer, Secretary
Vice President, Chief Legal Officer, Secretary
2.44K
+10.22%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Chemed Corp?

Die fünf größten Anteilseigner von Chemed Corp sind: Mr. Thomas Charles Hutton, J.D.

Wie viele Institutionen halten Anteile an Chemed Corp (CHE)?

Mit Stand vom 2026Q1 halten 1092 Institutionen Anteile an Chemed Corp, mit einem Gesamtmarktwert von etwa 13.97M, was 105.26% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -1981324.00 gestiegen.

Was ist die größte Einnahmequelle von Chemed Corp?

Am 2026Q1 erzielte das Geschäft mit Short-term core für Chemed Corp den höchsten Umsatz in Höhe von 653.69M, was 25.84% des Gesamtumsatzes entspricht.
KeyAI